Obstructive Lung Disease
-
Mucus plug gene expression could identify new COPD targets
Recent research has identified distinct gene clusters that may underly the clinical heterogeneity of mucus pathology and inform further studies, investigator Ehab Billatos, MD, said.
-
Hypoxic burden emerges as a key cardiovascular risk marker in pediatric OSA
Investigator Olga Mediano, PhD, said hypoxic burden may more fully capture the physiological consequences of OSA by integrating the frequency, duration, and depth of oxygen desaturation events.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
-
The climate cost of inhalers: What prescribers should know
Experts said clinicians must ensure patients have the therapies they need at affordable prices that, ideally, impose minimal amounts of environmental harm.
-
Oseltamivir found to lower risk of flu-linked neuropsychiatric events in children
This study is the largest and most comprehensive US investigation of the drug and severe neuropsychiatric events, said author James Antoon, MD, PhD, MPH.
-
Study explores geographic disparities in tobacco dependence treatment among veterans with COPD
Study author Arianne K. Baldomero, MD, said that reducing geographic barriers will require multidisciplinary approaches and innovative, equitable health care solutions.
-
Advocating for environmental justice on behalf of pediatric patients
Pediatric pulmonologists need to advocate for policies that promote environmental justice and help ensure that all children can grow up in safe, healthy environments.
-
Panelists address local approaches for clean air and climate action
Stephanie Lovinsky-Desir, MD, MS, presented on the health effects and mitigation of pollutant exposures at or near schools.
-
Clinicians share advice for working with vulnerable patient populations
Laura J. Spece, MD, MSc, spoke about specific respiratory health concerns for US military veterans during a session that also focused on optimizing care for patients who are transgender, patients shifting from pediatric to adult care, and patients with limited language proficiency.
-
Specialists to share latest updates in pediatric pulmonary medicine
Eric Mull, DO, will chair a Wednesday morning session on the latest developments in pediatric pulmonary medicine, including advances in extracorporeal membrane oxygenation (ECMO), bronchoscopies, and non-invasive ventilation.
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
Panel to introduce new CHEST North American bronchiectasis guidelines
Ashwin Basavaraj, MD, FCCP, will chair a Tuesday afternoon session summarizing CHEST’s North American bronchiectasis guidelines, their development process, and a case-based scenario for implementing their recommendations.
